Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131877) titled 'Early clinical study of digoxin combined with targeted chemotherapy drugs in the treatment of newly diagnosed acute myeloid leukemia' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
acute myelocytic leukemia
Recruitment Status: Not Recruiting
Phase: 1-2
Date of First Enrollment: 2026-09-10
Target Sample Size: combined therapy group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310622
Published by HT Digital Content Services with per...